Alvotech
Alvotech is a biotechnology company founded in 2013, focusing on the development and manufacture of biosimilar medicines to enhance access to essential biologic treatments globally.
Company facts
- Founded
- 2013
- Headquarters
- Iceland
- CEO
- Róbert Wessman
About
Alvotech is a pioneering biotechnology company that specializes in the development and manufacture of biosimilar medicines, founded in Reykjavik, Iceland, in 2013. We focus solely on making biologics more accessible and affordable, maintaining a strong commitment to improving patient outcomes worldwide. Our mission is simple yet profound: If there is a proven biologic medicine, we believe it should be accessible to all patients in need. This principle drives us to continually innovate and expand our product offerings to benefit patients globally. We utilize a vertically integrated approach that encompasses everything from cell line development to fill and finish manufacturing. By maintaining stringent quality controls and meeting the highest standards set by authorities like the FDA and EMA, we ensure that our biosimilars adhere to the principal theories of efficacy and safety. Our state-of-the-art facility in Reykjavik serves as the heart of our operations, where we combine technological advancements with a passionate workforce dedicated to excellence. Our culture is purpose-driven and emphasizes respect, unity, and strength—values that empower our team to touch the lives of patients every day.